Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-16

FDA Approved: BIVALIRUDIN — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Meitheal Pharmaceuticals' original application for generic bivalirudin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bivalirudin (bivalirudin)

Snippet

ORIG AP for BIVALIRUDIN (BIVALIRUDIN)